Skip to main content
logo
Cannara Biotech Inc. (LOVFF)
OTCMKTS · Delayed Price · Currency is USD
1.400
+0.040 (2.94%)
At close: Feb 11, 2026

Cannara Biotech Revenue

Cannara Biotech had revenue of 30.11M CAD in the quarter ending November 30, 2025, with 20.11% growth. This brings the company's revenue in the last twelve months to 112.36M, up 28.06% year-over-year. In the fiscal year ending August 31, 2025, Cannara Biotech had annual revenue of 107.32M with 30.64% growth.

Revenue (ttm)
112.36M CAD
Revenue Growth
+28.06%
P/S Ratio
1.68
Revenue / Employee
248.58K CAD
Employees
452
Market Cap
135.20M USD

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Aug 31, 2025107.32M25.17M30.64%
Aug 31, 202482.15M24.59M42.71%
Aug 31, 202357.56M21.57M59.91%
Aug 31, 202236.00M18.73M108.48%
Aug 31, 202117.27M15.17M723.42%
Aug 31, 20192.10M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sofgen Pharma423.75M
Jushi Holdings260.43M
MariMed157.38M
Elite Pharmaceuticals122.89M
Earth Science Tech33.84M
Radnostix14.07M
Healthy Extracts3.59M
Growth Stalk Holdings583.34K
Revenue Rankings

Cannara Biotech News

More News